Products - COVID-19 | Topic | NICE

Showing 5 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Molnupiravir for treating COVID-19 (TA1056)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
16 April 2025
Sabizabulin for treating COVID-19 [TSID11814]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Vilobelimab for treating COVID-19 [TSID11815]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sipavibart for preventing COVID-19 [ID6282]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Dapsone for treating COVID-19 in people 40 years and over with high-risk comorbidity and people 70 years and over [TSID11892]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC